Invasive procedures for fetal karyotyping: no cause of subsequent gestational hypertension or pre-eclampsia.
case_control · Level III
Where this comes from
- Record sourced from PubMed, PMID 21126321.
- Also identified by DOI 10.1111/j.1471-0528.2010.02665.x.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The aim was to estimate the risk of maternal hypertensive complications following first- or second-trimester invasive diagnostic procedures, i.e. chorionic villus sampling (CVS) and amniocentesis (AC). Odds ratios (ORs) for gestational hypertension, mild pre-eclampsia or severe pre-eclampsia were calculated for women who underwent CVS (n = 1,984) or AC (n = 21,748) compared with non-exposed women (n = 47,854). No increase in the development of gestational hypertension, mild pre-eclampsia or severe pre-eclampsia was observed. The results do not support an association between invasive procedures for fetal karyotyping and subsequent gestational hypertension or pre-eclampsia.
Medical subject headings
- Amniocentesis
- Chorionic Villi Sampling
- Hypertension, Pregnancy-Induced
- Karyotyping
- Pre-Eclampsia